Sanofi (LON:0A2V)

Market Cap	87.83B
Revenue (ttm)	40.09B
Net Income (ttm)	7.95B
Shares Out	n/a
EPS (ttm)	6.45
PE Ratio	11.04
Forward PE	10.07
Dividend	1.20 (2.50%)
Ex-Dividend Date	May 9, 2025

Volume	592
Average Volume	49,424
Open	46.56
Previous Close	48.01
Day's Range	46.56 - 49.59
52-Week Range	44.39 - 60.08
Beta	n/a
RSI	44.07
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A2V

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.

Financial numbers in EUR